Search

everythinglearnresearchcommunity

for

Search:↓

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Hair follicle-derived melanocyte transplant could effectively treat vitiligo by restoring skin color.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

Human hair follicles have a scent receptor that can influence hair growth.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Dermal Wnt/β-catenin signaling is important for the proper size and development of hair follicles.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

Live imaging helps us understand skin immune responses and develop treatments.

A man had both alopecia areata and lichen planus, which is uncommon.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Synthetic melanin applied to skin speeds up wound healing.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Targeting specific cell interactions may help treat skin fibrosis.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.